版本:
中国

BRIEF-International Stem Cell receives approval to start second patient cohort in clinical trial for Parkinson’s disease

May 9 International Stem Cell Corp:

* International Stem Cell Corporation receives approval to start second patient cohort in clinical trial for parkinson’s disease

* International Stem Cell Corp - DSMB has authorized clinical trial to move forward with accelerated enrollment and dose escalation to second cohort Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐